Skip to main content
Illumina10-Q: Acquisition completed

Completed acquisition of SomaLogic from Standard BioTools for $460 million total purchase price

Source: Autobound Signal API · 107 signals tracked for Illumina · updated

Get Illumina's live signals in Claude or ChatGPT, or by API

AskWhat changed at Illumina this week? Use Autobound signals for illumina.com.

What happened

Illumina acquired proteomics company SomaLogic on January 30, 2026, for $382 million cash and $81 million in estimated contingent consideration. Integration of new manufacturing and proteomics data analysis platforms may require specialized life sciences IT, laboratory integration, and data management solutions.

Source

SEC EDGARMay 1, 2026

Quarterly report (Form 10-Q)

Illumina 10-Q for Quarter ended Mar 29, 2026

Filing excerpt

On January 30, 2026, we acquired SomaLogic for a total purchase price of $460 million, including cash of $382 million and contingent consideration with an estimated fair value of $81 million, offset by $3 million for settlement of a preexisting relationship.

sec.gov/Archives/edgar/data/1110803/000111080326000092/ilmn-20260329.htmRead the full source

Other signals in this filing (1)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Period
Quarter ended Mar 29, 2026
Fiscal year end
03/29
Filed
May 1, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$460M (total purchase price for SomaLogic acquisition)

Details

CIK
1110803
Accession number
0001110803-26-000092
Timeframe
Current quarter
Quarter
Q1
Filing year
2026
Period end date
Mar 29, 2026
Why it matters
Active integration needs
Signal category
Strategic

Topics and mentions

Technologies

  • high-throughput protein measurement technology
  • SOMAmer-based NGS library preparation kits

Extraction

Confidence
High
Relevance
85%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
acquisitionCompleted

Use this data

Get every 10-Q signal for Illumina and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Illumina this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/580d38bc-5a23-4d2c-9171-4e92b82489b2 returns this record as JSON. POST /v1/companies/enrich returns every signal for illumina.com.

{
  "signal_id": "580d38bc-5a23-4d2c-9171-4e92b82489b2",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-11-09T06:24:49.452+00:00",
  "company": {
    "name": "Illumina",
    "domain": "illumina.com"
  },
  "data": {
    "detail": "Illumina acquired proteomics company SomaLogic on January 30, 2026, for $382 million cash and $81 million in estimated contingent consideration. Integration of new manufacturing and proteomics data analysis platforms may require specialized life sciences IT, laboratory integration, and data management solutions.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "total purchase price for SomaLogic acquisition",
      "dollar_millions": 460
    },
    "quarter": "Q1",
    "summary": "Completed acquisition of SomaLogic from Standard BioTools for $460 million total purchase price",
    "excerpts": "On January 30, 2026, we acquired SomaLogic for a total purchase price of $460 million, including cash of $382 million and contingent consideration with an estimated fair value of $81 million, offset by $3 million for settlement of a preexisting relationship.",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080326000092/ilmn-20260329.htm",
    "filing_date": "2026-05-01",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "03/29",
    "period_end_date": "2026-03-29",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic",
    "technologies_mentioned": [
      "high-throughput protein measurement technology",
      "SOMAmer-based NGS library preparation kits"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.